Skip to main content
Erschienen in: Infection 6/2016

03.05.2016 | Case Report

Carbapenem-resistant Lactobacillus intra-abdominal infection in a renal transplant recipient with a history of probiotic consumption

verfasst von: Jakapat Vanichanan, Violeta Chávez, Audrey Wanger, Aleksandra M. De Golovine, Karen J. Vigil

Erschienen in: Infection | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Lactobacillus sp. is a low virulence bacterium, which rarely causes infection in immunocompetent individuals and usually is considered a contaminant. Normally this organism is susceptible to β-lactam antibiotics, yet resistant strains have been reported.

Case presentation and discussion

Here, we report a case of a 60-year-old renal transplant recipient who developed an intra-abdominal abscess which grew a carbapenem-resistant Lactobacillus casei. This is significant since it is the first report of a clinical isolate of Lactobacillus sp. that demonstrated both microbiological and clinical resistance to carbapenem use. Moreover, the probiotic supplement that the patient had taken also grew a similar organism raising the concern of probiotic associated infection in immunocompromised individual.
Literatur
1.
Zurück zum Zitat Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis. 1997;25:1048–55.CrossRefPubMed Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis. 1997;25:1048–55.CrossRefPubMed
2.
Zurück zum Zitat Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005;24:31–40.CrossRefPubMed Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005;24:31–40.CrossRefPubMed
3.
Zurück zum Zitat Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on L. rhamnosus GG. Clin Infect Dis. 2004;38:62–9.CrossRefPubMed Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on L. rhamnosus GG. Clin Infect Dis. 2004;38:62–9.CrossRefPubMed
4.
Zurück zum Zitat Antony SJ, Stratton CW, Dummer JS. Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis. 1996;23:773–8.CrossRefPubMed Antony SJ, Stratton CW, Dummer JS. Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis. 1996;23:773–8.CrossRefPubMed
5.
Zurück zum Zitat Shields RK, Clancy CJ, Minces LR, Shigemura N, Kwak EJ, Silveira FP, et al. Epidemiology and outcomes of deep surgical site infections following lung transplantation. Am J Transplant. 2013;13:2137–45.CrossRefPubMed Shields RK, Clancy CJ, Minces LR, Shigemura N, Kwak EJ, Silveira FP, et al. Epidemiology and outcomes of deep surgical site infections following lung transplantation. Am J Transplant. 2013;13:2137–45.CrossRefPubMed
6.
Zurück zum Zitat Robin F, Paillard C, Marchandin H, Demeocq F, Bonnet R, Hennequin C. Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in child undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2010;48:4317–9.CrossRefPubMedPubMedCentral Robin F, Paillard C, Marchandin H, Demeocq F, Bonnet R, Hennequin C. Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in child undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2010;48:4317–9.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006;42:e35–44.CrossRefPubMed Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006;42:e35–44.CrossRefPubMed
9.
Zurück zum Zitat Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. ClustalW and ClustalX version 2 (2007). Bioinformatics. 2007;23(21):2947–8.CrossRefPubMed Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. ClustalW and ClustalX version 2 (2007). Bioinformatics. 2007;23(21):2947–8.CrossRefPubMed
10.
Zurück zum Zitat Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DM, Keating MR. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994;18:207–12.CrossRefPubMed Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DM, Keating MR. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994;18:207–12.CrossRefPubMed
11.
Zurück zum Zitat Carretto E, Barbarini D, Marzani FC, Fumagalli P, Monzillo V, Marone P, Emmi V. Catheter-related bacteremia due to Lactobacillus rhamnosus in a single-lung transplant recipient. Scan J Infect Dis. 2001;33:780–2.CrossRef Carretto E, Barbarini D, Marzani FC, Fumagalli P, Monzillo V, Marone P, Emmi V. Catheter-related bacteremia due to Lactobacillus rhamnosus in a single-lung transplant recipient. Scan J Infect Dis. 2001;33:780–2.CrossRef
12.
Zurück zum Zitat Jones SD, Fullerton DA, Zamora MR, Badesch DB, Campbell DN, Grover FL. Transmission of Lactobacillus pneumonia by transplanted lung. Ann Thorac Surg. 1994;58:887–9.CrossRefPubMed Jones SD, Fullerton DA, Zamora MR, Badesch DB, Campbell DN, Grover FL. Transmission of Lactobacillus pneumonia by transplanted lung. Ann Thorac Surg. 1994;58:887–9.CrossRefPubMed
13.
Zurück zum Zitat Klare I, Konstabel C, Werner G, Huys G, Vankerckhoven V, Kahlmeter G, et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother. 2007;59:900–12.CrossRefPubMed Klare I, Konstabel C, Werner G, Huys G, Vankerckhoven V, Kahlmeter G, et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother. 2007;59:900–12.CrossRefPubMed
14.
Zurück zum Zitat Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H. Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections. Antimicrob Agents Chemother. 2002;46:1136–40.CrossRefPubMedPubMedCentral Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H. Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections. Antimicrob Agents Chemother. 2002;46:1136–40.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Murray PR, Niles AC. In vitro activity of meropenem (SM-7338), imipenem and five other antibiotics against anaerobic clinical isolates. Diagn Microbiol Infect Dis. 1990;13:57–61.CrossRefPubMed Murray PR, Niles AC. In vitro activity of meropenem (SM-7338), imipenem and five other antibiotics against anaerobic clinical isolates. Diagn Microbiol Infect Dis. 1990;13:57–61.CrossRefPubMed
16.
Zurück zum Zitat Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010;7:503–14.CrossRefPubMedPubMedCentral Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010;7:503–14.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P. Supply of pre-and probiotics reduces bacterial infection rates after liver transplantation- a randomized, double-blind trial. Am J Transplant. 2005;5:125–30.CrossRefPubMed Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P. Supply of pre-and probiotics reduces bacterial infection rates after liver transplantation- a randomized, double-blind trial. Am J Transplant. 2005;5:125–30.CrossRefPubMed
18.
Zurück zum Zitat Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651–9.CrossRefPubMed Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651–9.CrossRefPubMed
19.
Zurück zum Zitat Vahabnezhad Z, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013;47:437–9.CrossRefPubMed Vahabnezhad Z, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013;47:437–9.CrossRefPubMed
20.
Zurück zum Zitat Luong ML, Sareyyupoglu B, Nguyen MH, Silveira FP, Shields RK, Potoski BA, et al. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection. Transpl Infect Dis. 2010;12:561–4.CrossRefPubMed Luong ML, Sareyyupoglu B, Nguyen MH, Silveira FP, Shields RK, Potoski BA, et al. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection. Transpl Infect Dis. 2010;12:561–4.CrossRefPubMed
Metadaten
Titel
Carbapenem-resistant Lactobacillus intra-abdominal infection in a renal transplant recipient with a history of probiotic consumption
verfasst von
Jakapat Vanichanan
Violeta Chávez
Audrey Wanger
Aleksandra M. De Golovine
Karen J. Vigil
Publikationsdatum
03.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0903-1

Weitere Artikel der Ausgabe 6/2016

Infection 6/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.